Lido Rx
Product Images NDC 35781-0300

This is LIDOR 3%, a topical anesthetic that contains Lidocaine Hydrochloride 3%. It is available by prescription and dispensed in the original container. The product is applied as a thin layer to the affected skin area 3-4 times, and may cause erythema or edema around the site of application. It should be used with caution in elderly, debilitated patients and children. LIDOR 3% should not be used in large quantities, particularly over raw surfaces, or on children under two years of age, except as directed by a physician. If any irritation or sensitivity occurs, or an infection appears, it is recommended to discontinue use and appropriate therapy should be instituted. In case of methemoglobinemia, which is a serious condition that reduces the amount of oxygen carried in blood, immediate medical attention is required. LIDOR 3% should be stored at 25°C (77°F); excursions are permitted to 15-30°C (59-86°F), and it should be protected from freezing.*

LiDORx 3% is a topical anesthetic for external use only that contains Lidocaine Hydrochloride USP. It is applied to the affected area of the skin 3-4 times and can cause erythema or edema. Caution should be exercised when using the product on children under 2 years, the elderly, debilitated patients, and those who may be more sensitive to the systemic effects of Lidocaine Hydrochloride USP. The product may cause methemoglobinemia, so users should seek immediate medical attention if symptoms such as pale, gray, or blue-colored skin, headache, rapid heart rate, shortness of breath, dizziness or lightheadedness, fatigue, or lack of energy occur. The medicine should be stored in its original container and kept between 15°C-30°C (69°-86°F).*

This text is a description of a topical anesthetic called LIDORX 3%. It provides information about the dosage and administration of the medication, possible adverse reactions, warnings, storage, active and inactive ingredients, and manufacturing details. It also warns against using the medication on children under 2 years of age, using it in large quantities or over raw surfaces, and mentions potential side effects such as methemoglobinemia. The text includes a list of contact information for the manufacturer, GEN§RCMOA Gensco Pharma, LLC.*